Mark E. Burkard
Impact in
- Cell Biology top 1%
- Microtubule and mitosis dynamics
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
- Cell Biology 33
- Microtubule and mitosis dynamics 32
-
- Breast Cancer Treatment Studies 11
- Cancer Genomics and Diagnostics 9
- Co-authors
- Douglas H. Turner (10 shared papers)Ryszard Kierzek (3 shared papers)Hugh D. Van Liew (13 shared papers)Susan J. Schroeder (3 shared papers)Tianbing Xia (2 shared papers)John SantaLucia (1 shared paper)Christopher Cox (1 shared paper)Beth A. A. Weaver (14 shared papers)
- Journals
- JCO Precision Oncology (6 papers)Biochemistry (6 papers)Journal of Applied Physiology (6 papers)Clinical Breast Cancer (6 papers)Breast Cancer Research and Treatment (5 papers)
- Partner nations
- United StatesPolandChina
In The Last Decade
Mark E. Burkard
113 papers receiving 5.3k citations
Mark E. Burkard's Hit Papers
Peers
Comparison fields: 5 of 124
- Cell Biology 927
- Cancer Research 506
- Endocrinology, Diabetes and Metabolism 543
- Molecular Biology 2k
- Oncology 562
Countries citing papers authored by Mark E. Burkard
This map shows the geographic impact of Mark E. Burkard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Burkard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Burkard more than expected).
Fields of papers citing papers by Mark E. Burkard
This network shows the impact of papers produced by Mark E. Burkard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Burkard. The network helps show where Mark E. Burkard may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Burkard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Thermodynamic Parameters for an Expanded Nearest-Neighbor Model for Formation of RNA Duplexes with Watson−Crick Base Pairs Hit paper breakdown → | 1998 | 949 |
| 2 | Efficacy of Selpercatinib in RET -Altered Thyroid Cancers Hit paper breakdown → | 2020 | 593 |
| 3 | Selective RET kinase inhibition for patients with RET-altered cancers Hit paper breakdown → | 2018 | 363 |
| 4 | 2014 | 331 | |
| 5 | 1999 | 225 | |
| 6 | 2007 | 210 | |
| 7 | 2019 | 188 | |
| 8 | 2009 | 158 | |
| 9 | 1999 | 139 | |
| 10 | 2020 | 111 | |
| 11 | 2021 | 99 | |
| 12 | 2016 | 96 | |
| 13 | 2021 | 94 | |
| 14 | 1999 | 79 | |
| 15 | 2017 | 68 | |
| 16 | 2017 | 68 | |
| 17 | 2019 | 68 | |
| 18 | 1995 | 62 | |
| 19 | The oxygen window and decompression bubbles: estimates and significance. | 1993 | 61 |
| 20 | 2018 | 56 |
About Mark E. Burkard
Mark E. Burkard is a scholar working on Cell Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 116 papers that have together received 5.5k indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (32 papers), Breast Cancer Treatment Studies (11 papers), RNA and protein synthesis mechanisms (10 papers), Cancer Genomics and Diagnostics (9 papers), Cardiovascular and Diving-Related Complications (8 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). The work is most often cited by research in Cell Biology (927 citations), Cancer Research (506 citations), Endocrinology, Diabetes and Metabolism (543 citations), Molecular Biology (2k citations) and Oncology (562 citations). Mark E. Burkard has collaborated with scholars based in United States, Poland and China. Frequent co-authors include Douglas H. Turner, Ryszard Kierzek, Hugh D. Van Liew, Susan J. Schroeder, Tianbing Xia, John SantaLucia, Christopher Cox, Beth A. A. Weaver, Prasad V. Jallepalli and Lauren M. Zasadil. Their work appears in journals such as JCO Precision Oncology, Biochemistry, Journal of Applied Physiology, Clinical Breast Cancer and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.